{
  "relevance_rule": {},
  "priority_rules": [
    {
      "priority": "High",
      "rule_text": "EGFR Bispecific, EGFR AND CRC, EGFR-targeted AND CRC, CRC AND MSS, CRC AND RAS-WT, CRC AND BRAF-WT, CRC AND CTLA-4, CRC AND refractory, Keynote-689, Locally advanced AND HNSCC, GUCY2C, Buparlisib, BURAN",
      "approach": "keywords",
      "key_concepts": {
        "keywords": [
          "EGFR Bispecific",
          "EGFR AND CRC",
          "EGFR-targeted AND CRC",
          "CRC AND MSS",
          "CRC AND RAS-WT",
          "CRC AND BRAF-WT",
          "CRC AND CTLA-4",
          "CRC AND refractory",
          "Keynote-689",
          "Locally advanced AND HNSCC",
          "GUCY2C",
          "Buparlisib",
          "BURAN"
        ],
        "categories": [
          "High Priority Client Keywords"
        ],
        "contextual_concepts": []
      },
      "exclusions": [
        "ADC for CRC",
        "WRN (werner syndrome helicase)",
        "CEACAM5",
        "CDH17",
        "CRC AND Vaccines",
        "c-MET",
        "EpCAM",
        "Petosemtamab",
        "Ficerafusp",
        "AZD9592",
        "INBRX-106",
        "Zanzalintinib",
        "Ficlatuzumab"
      ],
      "reasoning": "All terms are direct client keywords and can be matched using keyword search. Exclusions are Medium priority keywords to ensure mutual exclusivity."
    },
    {
      "priority": "Medium",
      "rule_text": "any ADC for CRC, WRN (werner syndrome helicase), CEACAM5, CDH17, CRC AND Vaccines, c-MET, EpCAM, Petosemtamab, Ficerafusp, AZD9592, INBRX-106, Zanzalintinib, Ficlatuzumab",
      "approach": "keywords",
      "key_concepts": {
        "keywords": [
          "ADC for CRC",
          "WRN (werner syndrome helicase)",
          "CEACAM5",
          "CDH17",
          "CRC AND Vaccines",
          "c-MET",
          "EpCAM",
          "Petosemtamab",
          "Ficerafusp",
          "AZD9592",
          "INBRX-106",
          "Zanzalintinib",
          "Ficlatuzumab"
        ],
        "categories": [
          "Medium Priority Client Keywords"
        ],
        "contextual_concepts": []
      },
      "exclusions": [
        "EGFR Bispecific",
        "EGFR AND CRC",
        "EGFR-targeted AND CRC",
        "CRC AND MSS",
        "CRC AND RAS-WT",
        "CRC AND BRAF-WT",
        "CRC AND CTLA-4",
        "CRC AND refractory",
        "Keynote-689",
        "Locally advanced AND HNSCC",
        "GUCY2C",
        "Buparlisib",
        "BURAN"
      ],
      "reasoning": "All terms are direct client keywords and can be matched using keyword search. Exclusions are High priority keywords to ensure mutual exclusivity."
    }
  ]
}